StockOtters
StockOttersSupply Chain Map
Gan & Lee Pharmaceuticals. logo

Gan & Lee Pharmaceuticals.

603087.SS

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
426
Cost of Revenue
109
Gross Profit
318
Gross Margin
74.5%
Operating Income
88
Operating Margin
20.7%
Net Income
86
Net Margin
20.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
76
EBITDA Margin
17.9%

2023

12/31/2023

Revenue
365
Cost of Revenue
101
Gross Profit
264
Gross Margin
72.2%
Operating Income
44
Operating Margin
12.1%
Net Income
48
Net Margin
13.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
56
EBITDA Margin
15.4%

2022

12/31/2022

Revenue
240
Cost of Revenue
62
Gross Profit
178
Gross Margin
74.1%
Operating Income
-80
Operating Margin
-33.2%
Net Income
-62
Net Margin
-25.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-67
EBITDA Margin
-28.0%

2021

12/31/2021

Revenue
506
Cost of Revenue
56
Gross Profit
450
Gross Margin
88.9%
Operating Income
238
Operating Margin
47.0%
Net Income
203
Net Margin
40.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
220
EBITDA Margin
43.5%

2020

12/31/2020

Revenue
471
Cost of Revenue
43
Gross Profit
427
Gross Margin
90.8%
Operating Income
203
Operating Margin
43.2%
Net Income
172
Net Margin
36.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
220
EBITDA Margin
46.8%